Aquestive Therapeutics, Inc. Tax Withholding Paid on Stock Awards
Aquestive Therapeutics, Inc. (AQST) reported Tax Withholding Paid on Stock Awards of $3.57 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation · last filed 2026-08-11
- Aquestive Therapeutics, Inc. payment, tax withholding, share-based payment arrangement for the quarter ending 2026-06-30 was $3.24M, a 16957.89% increase year-over-year.
- Aquestive Therapeutics, Inc. payment, tax withholding, share-based payment arrangement for the quarter ending 2026-03-31 was $329.00K, a 53.20% decline year-over-year.
- Aquestive Therapeutics, Inc. payment, tax withholding, share-based payment arrangement for the quarter ending 2025-12-31 was $18.00K, a 1700.00% increase year-over-year.
- Aquestive Therapeutics, Inc. payment, tax withholding, share-based payment arrangement for the quarter ending 2025-09-30 was $70.00K, a 65.35% decline year-over-year.
- Aquestive Therapeutics, Inc. payment, tax withholding, share-based payment arrangement for fiscal 2025 was $810.00K, a 26.43% decline from fiscal 2024.
- Aquestive Therapeutics, Inc. payment, tax withholding, share-based payment arrangement for fiscal 2024 was $1.10M, a 9909.09% increase from fiscal 2023.
- Aquestive Therapeutics, Inc. payment, tax withholding, share-based payment arrangement for fiscal 2023 was $11.00K, a 266.67% increase from fiscal 2022.
- Aquestive Therapeutics, Inc. payment, tax withholding, share-based payment arrangement for fiscal 2022 was $3.00K, a 78.57% decline from fiscal 2021.
| Period end | Payment, Tax Withholding, Share-based Payment Arrangement 3 month | Payment, Tax Withholding, Share-based Payment Arrangement 6 month | Payment, Tax Withholding, Share-based Payment Arrangement 9 month | Payment, Tax Withholding, Share-based Payment Arrangement 12 month |
|---|---|---|---|---|
| 2026-06-30 | $3.24M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | $3.57M 10-Q · filed 2026-08-11 | $3.59M derived: sum of 3 quarters · filed 2026-08-11 | $3.66M derived: sum of 4 quarters · filed 2026-08-11 |
| 2026-03-31 | $329.00K 10-Q · filed 2026-05-13 | $347.00K derived: sum of 2 quarters · filed 2026-05-13 | $417.00K derived: sum of 3 quarters · filed 2026-05-13 | $436.00K derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-12-31 | $18.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | $88.00K derived: sum of 2 quarters · filed 2026-03-04 | $107.00K derived: sum of 3 quarters · filed 2026-08-11 | $810.00K 10-K · filed 2026-03-04 |
| 2025-09-30 | $70.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $89.00K derived: sum of 2 quarters · filed 2026-08-11 | $792.00K 10-Q · filed 2025-11-05 | $793.00K derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-06-30 | $19.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | $722.00K 10-Q · filed 2026-08-11 | $723.00K derived: sum of 3 quarters · filed 2026-08-11 | $925.00K derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-03-31 | $703.00K 10-Q · filed 2026-05-13 | $704.00K derived: sum of 2 quarters · filed 2026-05-13 | $906.00K derived: sum of 3 quarters · filed 2026-05-13 | $911.00K derived: sum of 4 quarters · filed 2026-05-13 |
| 2024-12-31 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | $203.00K derived: sum of 2 quarters · filed 2026-03-04 | $208.00K derived: sum of 3 quarters · filed 2026-03-04 | $1.10M 10-K · filed 2026-03-04 |
| 2024-09-30 | $202.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $207.00K derived: sum of 2 quarters · filed 2025-11-05 | $1.10M 10-Q · filed 2025-11-05 | $1.10M derived: sum of 4 quarters · filed 2025-11-05 |
| 2024-06-30 | $5.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-11 | $898.00K 10-Q · filed 2025-08-11 | $898.00K derived: sum of 3 quarters · filed 2025-08-11 | $898.00K derived: sum of 4 quarters · filed 2025-08-11 |
| 2024-03-31 | $893.00K 10-Q · filed 2025-05-12 | $893.00K derived: sum of 2 quarters · filed 2025-05-12 | $893.00K derived: sum of 3 quarters · filed 2025-05-12 | $896.00K derived: sum of 4 quarters · filed 2025-05-12 |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-05 | $0.00 derived: sum of 2 quarters · filed 2025-03-05 | $3.00K derived: sum of 3 quarters · filed 2025-03-05 | $11.00K 10-K · filed 2025-03-05 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-04 | $3.00K derived: sum of 2 quarters · filed 2024-11-04 | $11.00K 10-Q · filed 2024-11-04 | $11.00K derived: sum of 4 quarters · filed 2024-11-04 |
| 2023-06-30 | $3.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | $11.00K 10-Q · filed 2024-08-06 | $11.00K derived: sum of 3 quarters · filed 2024-08-06 | $14.00K derived: sum of 4 quarters · filed 2024-08-06 |
| 2023-03-31 | $8.00K 10-Q · filed 2024-05-07 | $8.00K derived: sum of 2 quarters · filed 2024-05-07 | $11.00K derived: sum of 3 quarters · filed 2024-05-07 | $11.00K derived: sum of 4 quarters · filed 2024-05-07 |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-05 | $3.00K derived: sum of 2 quarters · filed 2024-03-05 | $3.00K derived: sum of 3 quarters · filed 2024-03-05 | $3.00K 10-K · filed 2024-03-05 |
| 2022-09-30 | $3.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-06 | $3.00K derived: sum of 2 quarters · filed 2023-11-06 | $3.00K 10-Q · filed 2023-11-06 | $4.00K derived: sum of 4 quarters · filed 2023-11-06 |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-07 | $0.00 10-Q · filed 2023-08-07 | $1.00K derived: sum of 3 quarters · filed 2023-08-07 | $10.00K derived: sum of 4 quarters · filed 2023-08-07 |
| 2022-03-31 | $0.00 10-Q · filed 2023-05-02 | $1.00K derived: sum of 2 quarters · filed 2023-05-02 | $10.00K derived: sum of 3 quarters · filed 2023-05-02 | $14.00K derived: sum of 4 quarters · filed 2023-05-02 |
| 2021-12-31 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $10.00K derived: sum of 2 quarters · filed 2023-03-31 | $14.00K derived: sum of 3 quarters · filed 2023-03-31 | $14.00K 10-K · filed 2023-03-31 |
| 2021-09-30 | $9.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-01 | $13.00K derived: sum of 2 quarters · filed 2022-11-01 | $13.00K 10-Q · filed 2022-11-01 | $16.00K derived: sum of 4 quarters · filed 2022-11-01 |
| 2021-06-30 | $4.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-02 | $4.00K 10-Q · filed 2022-08-02 | $7.00K derived: sum of 3 quarters · filed 2022-08-02 | $14.00K derived: sum of 4 quarters · filed 2022-08-02 |
| 2021-03-31 | $0.00 10-Q · filed 2021-05-04 | $3.00K derived: sum of 2 quarters · filed 2022-03-08 | $10.00K derived: sum of 3 quarters · filed 2022-03-08 | $62.00K derived: sum of 4 quarters · filed 2022-03-08 |
| 2020-12-31 | $3.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-08 | $10.00K derived: sum of 2 quarters · filed 2022-03-08 | $62.00K derived: sum of 3 quarters · filed 2022-03-08 | $99.00K 10-K · filed 2022-03-08 |
| 2020-09-30 | $7.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-02 | $59.00K derived: sum of 2 quarters · filed 2021-11-02 | $96.00K 10-Q · filed 2021-11-02 | $200.00K derived: sum of 4 quarters · filed 2021-11-02 |
| 2020-06-30 | $52.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-03 | $89.00K 10-Q · filed 2021-08-03 | $193.00K derived: sum of 3 quarters · filed 2021-08-03 | $252.00K derived: sum of 4 quarters · filed 2021-08-03 |
| 2020-03-31 | $37.00K 10-Q · filed 2021-05-04 | $141.00K derived: sum of 2 quarters · filed 2021-05-04 | $200.00K derived: sum of 3 quarters · filed 2021-05-04 | $255.00K derived: sum of 4 quarters · filed 2021-05-04 |
| 2019-12-31 | $104.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-09 | $163.00K derived: sum of 2 quarters · filed 2021-03-09 | $218.00K derived: sum of 3 quarters · filed 2021-03-09 | $2.83M 10-K · filed 2021-03-09 |
| 2019-09-30 | $59.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-04 | $114.00K derived: sum of 2 quarters · filed 2020-11-04 | $2.72M 10-Q · filed 2020-11-04 | $2.85M derived: sum of 4 quarters · filed 2020-11-04 |
| 2019-06-30 | $55.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-04 | $2.66M 10-Q · filed 2020-08-04 | $2.79M derived: sum of 3 quarters · filed 2020-08-04 | $3.07M derived: sum of 4 quarters · filed 2020-08-04 |
| 2019-03-31 | $2.61M 10-Q · filed 2020-05-05 | $2.73M derived: sum of 2 quarters · filed 2020-05-05 | $3.01M derived: sum of 3 quarters · filed 2020-05-05 | $8.64M derived: sum of 4 quarters · filed 2020-05-05 |
| 2018-12-31 | $124.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-11 | $404.00K derived: sum of 2 quarters · filed 2020-03-11 | $6.03M derived: sum of 3 quarters · filed 2020-03-11 | $6.03M 10-K · filed 2020-03-11 |
| 2018-09-30 | $280.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | $5.90M derived: sum of 2 quarters · filed 2019-11-05 | $5.90M 10-Q · filed 2019-11-05 | $5.90M derived: sum of 4 quarters · filed 2019-11-05 |
| 2018-06-30 | $5.62M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | $5.62M 10-Q · filed 2019-08-06 | $5.62M derived: sum of 3 quarters · filed 2019-08-06 | $5.62M derived: sum of 4 quarters · filed 2019-08-06 |
| 2018-03-31 | $0.00 10-Q · filed 2019-05-08 | $0.00 derived: sum of 2 quarters · filed 2019-05-08 | $0.00 derived: sum of 3 quarters · filed 2019-05-08 | |
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-14 | $0.00 derived: sum of 2 quarters · filed 2019-03-14 | $0.00 10-K · filed 2019-03-14 | |
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | $0.00 10-Q · filed 2018-11-06 | ||
| 2017-06-30 | $0.00 10-Q · filed 2018-09-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| CytomX Therapeutics, Inc. (CTMX) | United States | $0.598B | -10.25 |
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |